Business Context and Reporting Period
Company: Medical Transcription Billing, Corp. (MTBC)
Filing Type: Form 8-K (Current Report)
Date of Report: August 15, 2017
Reporting Period: Event date of August 15, 2017
Business Context: The Company is an emerging growth company incorporated in Delaware. This filing reports the entry into a material definitive agreement regarding a public offering of preferred stock.
Key Financial Metrics
Capital Raised: Approximately $500,000 in net proceeds.
Instrument Issued: 23,695 shares of 11% Series A Cumulative Redeemable Preferred Stock.
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics. This report focuses solely on the capital raise event.
Material Changes
- Capital Structure Change: Issuance of 23,695 shares of 11% Series A Cumulative Redeemable Preferred Stock.
- Liquidity Impact: Receipt of approximately $500,000 in net proceeds after deducting placement agency fees and offering expenses.
- Agreement: Entry into a Placement Agency Agreement with Alexander Capital, LP.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the execution of the offering pursuant to a Registration Statement on Form S-3 (File No. 333-210391).
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard obligations of issuing redeemable preferred stock. A legal opinion regarding the legality of the stock was filed as an exhibit.
Unusual Items: None reported beyond the specific capital raise transaction.
Investor Verification Checklist
- Verify the terms of the 11% Series A Cumulative Redeemable Preferred Stock (redemption rights, dividend priority) in the Prospectus Supplement.
- Confirm the use of the $500,000 net proceeds as disclosed in the related Form S-3 filing.
- Review the Placement Agency Agreement (Exhibit 1.1) for any restrictive covenants or future obligations to Alexander Capital, LP.
- Check subsequent filings for the impact of the preferred stock dividends on future cash flow.